Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study

Tang, 2020, The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges, J. Clin. Microbiol., 58, e00512-20, 10.1128/JCM.00512-20 Pan, 2020, Viral load of SARS-CoV-2 in clinical samples, Lancet Infect. Dis., 20, 411, 10.1016/S1473-3099(20)30113-4 Long, 2020, Antibody responses to SARS-CoV-2 in patients with COVID-19, Nat. Med., 26, 845, 10.1038/s41591-020-0897-1 Wölfel, 2020, Virological assessment of hospitalized patients with COVID-2019, Nature, 581, 465, 10.1038/s41586-020-2196-x Carding, 2020 Vetter, 2020, Clinical features of covid-19, BMJ, 369, m1470, 10.1136/bmj.m1470 Lessells, 2020 Phua, 2020, Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations, Lancet Respir. Med., 8, 506, 10.1016/S2213-2600(20)30161-2 Rivett, 2020, Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission, eLife, 9, e58728, 10.7554/eLife.58728 Patterson, 2020, A Novel Cohorting and Isolation Strategy for Suspected COVID-19 Cases during a Pandemic, J. Hosp. Infect., 105, 632, 10.1016/j.jhin.2020.05.035 Lephart, 2020, Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type, bioRxiv Zhen, 2020, Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2, J. Clin. Microbiol., 10.1128/JCM.00783-20 Lieberman, 2020, Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories, J. Clin. Microbiol., 10.1128/JCM.00821-20 Smithgall, 2020, Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2, J. Clin. Virol., 128, 104428, 10.1016/j.jcv.2020.104428 Rhoads, 2020, Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19, J. Clin. Microbiol., 10.1128/JCM.00760-20 Visseaux, 2020, Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection, J. Clin. Microbiol., 10.1128/JCM.00630-20 Goel, 2017, Performance of the SAMBA I and II HIV-1 Semi-Q Tests for viral load monitoring at the point-of-care, J. Virol. Methods, 244, 39, 10.1016/j.jviromet.2017.03.001 Ondiek, 2017, Multicountry Validation of SAMBA - A Novel Molecular Point-of-Care Test for HIV-1 Detection in Resource-Limited Setting, J. Acquir. Immune Defic. Syndr., 76, e52, 10.1097/QAI.0000000000001476 Ritchie, 2020, Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2, MedRxiv 2020, Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study, Lancet, 396, 27, 10.1016/S0140-6736(20)31182-X Docherty, 2020, Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ, 369, m1985, 10.1136/bmj.m1985 Toye, 2019, Bed Moves, Ward Environment, Staff Perspectives and Falls for Older People with High Falls Risk in an Acute Hospital: A Mixed Methods Study, Clin. Interv. Aging, 14, 2223, 10.2147/CIA.S211424 Davis, 2017, Diagnostic accuracy and cost analysis of the Alere™ i Influenza A&B near-patient test using throat swabs, J. Hosp. Infect., 97, 301, 10.1016/j.jhin.2017.05.017 2020, COVID-19: endgames, Lancet Infect. Dis., 20, 511, 10.1016/S1473-3099(20)30298-X Zhao, 2020, Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Clin. Infect. Dis., 10.1093/cid/ciaa344 2020